SS Innovations International (NASDAQ: SSII) reported record second-quarter 2026 revenue of $13.9 million, a 39.4% increase from $10 million in the same period last year. The company attributed the growth to a 30.4% rise in installations of its SSi Mantra surgical robotic system, reaching 30 units during the quarter. Gross profit increased 20% to $7.1 million, with a gross margin of 50.9%, while net loss widened to $2.7 million, or $0.01 per diluted share, compared with a net loss of $0.3 million a year earlier.
The strong quarterly performance contributed to a robust first half, with revenue climbing 65.6% to $25 million and SSi Mantra installations rising 47.4% to 56. As of June 30, the company held $13.6 million in cash and cash equivalents, maintained no long-term debt, and had a cumulative installed base of 224 SSi Mantra systems across 12 countries. The company also reported 12,272 cumulative procedures using the SSi Mantra, including 175 telesurgeries, and highlighted a recent robotic telesurgery that spanned more than 13,600 miles between Colombia and India.
SS Innovations expects the U.S. Food and Drug Administration to complete its review of the SSi Mantra's 510(k) premarket notification by the end of the first quarter of 2027. Additionally, the company believes it can obtain European Union CE marking certification by the end of 2026. These regulatory milestones are critical for expanding the system's availability in major markets.
The financial results underscore SS Innovations' commitment to making robotic surgery affordable and accessible globally. With a focus on cardiac surgery and a comprehensive suite of SSi Mudra instruments, the company is positioned to capture a larger share of the surgical robotics market. The recent telesurgery achievement highlights the system's advanced capabilities and potential for remote surgical applications.
Investors can access the full press release at https://ibn.fm/nTMso. For more information about SS Innovations, visit the company's newsroom at https://ibn.fm/SSII.
